Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
+0.83%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$38.7B
AUM Growth
-$288M
(-0.74%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
2,583
New
583
Increased
631
Reduced
609
Closed
644
Top Buys
| 1 |
Apple
AAPL
|
+$502M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$448M |
| 3 |
Wells Fargo
WFC
|
+$282M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$272M |
| 5 |
ConocoPhillips
COP
|
+$220M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$777M |
| 2 |
TSMC
TSM
|
+$353M |
| 3 |
Meta Platforms (Facebook)
META
|
+$329M |
| 4 |
JPMorgan Chase
JPM
|
+$255M |
| 5 |
ASML
ASML
|
+$246M |
Sector Composition
| 1 | Industrials | 14.08% |
| 2 | Consumer Discretionary | 13.79% |
| 3 | Financials | 12.94% |
| 4 | Technology | 12.76% |
| 5 | Healthcare | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Origin Materials
ORGN
$81.4M
| $21K | ﹤0.01% |
+23,267
| New | +$21K |
|
1802
ESS Tech
GWH
$20.5M
| $20.7K | ﹤0.01% |
1,689
+375
| +29% | +$4.6K |
|
1803
5E Advanced Materials
FEAM
$92.9M
| $20.6K | ﹤0.01% |
+741
| New | +$20.6K |
|
1804
Planet Labs
PL
$2.98B
| $20.6K | ﹤0.01% |
+11,065
| New | +$20.6K |
|
1805
Eos Energy Enterprises
EOSE
$2.02B
| $20.5K | ﹤0.01% |
+16,166
| New | +$20.5K |
|
1806
Seer Inc
SEER
$116M
| $19.8K | ﹤0.01% |
+11,806
| New | +$19.8K |
|
1807
Karyopharm Therapeutics
KPTI
$57.6M
| $19.6K | ﹤0.01% |
+1,504
| New | +$19.6K |
|
1808
Microvast
MVST
$916M
| $19K | ﹤0.01% |
+41,725
| New | +$19K |
|
1809
Noodles & Co
NDLS
$30.1M
| $18.7K | ﹤0.01% |
+11,863
| New | +$18.7K |
|
1810
Maxeon Solar Technologies
MAXN
$67.1M
| $17.9K | ﹤0.01% |
+210
| New | +$17.9K |
|
1811
FibroGen
FGEN
$50.3M
| $17.3K | ﹤0.01% |
+776
| New | +$17.3K |
|
1812
Expensify
EXFY
$182M
| $16.9K | ﹤0.01% |
+11,325
| New | +$16.9K |
|
1813
Fossil Group
FOSL
$167M
| $16.1K | ﹤0.01% |
+11,162
| New | +$16.1K |
|
1814
Citius Pharmaceuticals
CTXR
$20.4M
| $15.8K | ﹤0.01% |
+1,082
| New | +$15.8K |
|
1815
Vuzix
VUZI
$183M
| $15.7K | ﹤0.01% |
+11,624
| New | +$15.7K |
|
|
ALLK
1816
DELISTED
Allakos
ALLK
| $15.7K | ﹤0.01% |
+15,654
| New | +$15.7K |
|
1817
Protalix BioTherapeutics
PLX
$139M
| $15.6K | ﹤0.01% |
+13,299
| New | +$15.6K |
|
1818
Aclaris Therapeutics
ACRS
$213M
| $15.3K | ﹤0.01% |
+13,910
| New | +$15.3K |
|
1819
Seres Therapeutics
MCRB
$154M
| $14.3K | ﹤0.01% |
+985
| New | +$14.3K |
|
|
NKGNW
1820
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| $13.8K | ﹤0.01% |
139,893
| – | – |
|
1821
Cue Biopharma
CUE
$58.8M
| $13.3K | ﹤0.01% |
+10,744
| New | +$13.3K |
|
|
VTNR
1822
DELISTED
Vertex Energy, Inc
VTNR
| $12.6K | ﹤0.01% |
+13,376
| New | +$12.6K |
|
|
KLRS
1823
Kalaris Therapeutics, Inc. Common Stock
KLRS
$80M
| $11.5K | ﹤0.01% |
+693
| New | +$11.5K |
|
|
GRTS
1824
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $11.5K | ﹤0.01% |
+18,644
| New | +$11.5K |
|
1825
Sangamo Therapeutics
SGMO
$160M
| $11.4K | ﹤0.01% |
+31,773
| New | +$11.4K |
|